NCT03192397 2026-04-14Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantRoswell Park Cancer InstitutePhase 1/2 Active not recruiting35 enrolled 19 charts
NCT03233854 2025-11-18CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell MalignanciesStanford UniversityPhase 1 Active not recruiting56 enrolled
NCT02159495 2025-09-16Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell NeoplasmCity of Hope Medical CenterPhase 1 Active not recruiting31 enrolled
NCT05182385 2025-07-25Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)Goethe UniversityPhase 1/2 Active not recruiting30 enrolled
NCT03241940 2025-06-29Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults w/ Recurrent or Refractory B Cell MalignanciesStanford UniversityPhase 1 Active not recruiting33 enrolled
NCT03863184 2025-06-06Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCLWeill Medical College of Cornell UniversityPhase 2 Active not recruiting37 enrolled 9 charts
NCT03459170 2022-07-12Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo TransplantBellicum PharmaceuticalsPhase 1 Active not recruiting15 enrolled